This Dog’s AI-Designed Cancer Treatment May Signal New Era of Programmable Medicine

The future of medicine just got its first beta release. A tech executive used ChatGPT and Google’s DeepFold to design a personalized cancer vaccine for his dog by analyzing her DNA. The tumor wasn’t eliminated, but her quality of life improved. EMJ Capital CIO Eric Jackson called this shift “the first real version of programmable medicine people have been talking about but haven’t really seen yet.”

• AI is rapidly eroding Big Pharma’s drug discovery moat, though PfizerPFE
  and MerckMRK
  still retain advantages in regulation and distribution.
• Platforms like RecursionRXRX
  , SchrodingerSDGR
  , and ModernaMRNA
  are positioned to benefit as this shift accelerates.

The verdict: Manufacturing each custom vaccine still takes about 30 days and costs over $100K per patient, making scale the biggest hurdle. That said, the FDA has started to move, issuing draft guidance in early 2026 for individualized therapies like genome editing and RNA-based treatments. As UNSW’s Páll Thordarson put it, if the technology can work for a dog, “Ultimately, we’re going to use this for helping humans” — a sign it’s “democratizing the whole process.” Now it’s a race between scientific progress and system-wide bottlenecks.